Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2008-02-19

FDA Approved: OXYBUTYNIN CHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved a supplemental application for oxybutynin chloride by Teva Pharmaceuticals USA, resulting in changes to the existing approved product under ANDA071…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oxybutynin chloride (Oxybutynin chloride)

Snippet

SUPPL AP for OXYBUTYNIN CHLORIDE (OXYBUTYNIN CHLORIDE)